Tag: Vaccination

  • COVID Vaccines Continue to Evolve

    Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines. Federal officials have signaled that second boosters for those under 50 are on hold to speed production of new bivalent shots. The new bivalent booster shots will include the original […]

  • Westward Wave of COVID Continues – as Projected

    Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine, Adjuvante. On July 13, the USDA issued an emergency use authorization for Novavax COVID-19, Adjuvante vaccine for individuals 18 years of age and older. The FDA […]

  • COVID Trends Continue, but Severity Remains Low

    Key Points: In today’s Recommendation for Industry, we discuss the current data on COVID case rates and hospitalizations. Read more below. FDA committee approves Moderna COVID vaccine for kids 6 to 17. Previously only Pfizer was approved for ages 5-17 and the CDC had recommended that age range receive a single-dose booster. The CDC reports […]

  • Cases Seem to be Improving and Moving Across the Country

    Key Points: In today’s Recommendation for Industry, we discuss how cases seem to be improving and moving across the country, as shown through the CDC community levels map and our weekly matrix. Read more below. Global COVID-19 cases fall 11%, deaths drop 3%. Since January, cases have steadily fallen over the world. Some areas of […]

  • Virus Update: COVID Masks, Hepatitis Outbreak

    Key Points: In today’s Recommendation for Industry, we discuss COVID masking and the Hepatitis A outbreak. Read more below. Vaccines lower risk of long COVID 15%, death by 34%, data show. The vaccines were shown to be the most effective for lung disorders and blood clots. Those who tested positive for COVID-19 after vaccination faced […]

  • Prepare Your Business for Omicron Variant Reinfections

    Key Points: In today’s Recommendations for Industry, we discuss COVID-19 variants, BA.4 and BA.5. Read more below. Despite what many of us might like to believe, COVID-19 has not gone away. South Africa recently identified two new subvariants of Omicron – designated BA.4 and BA.5. These subvariants have now spread to several other countries, including […]

  • Variants Continue to Evolve. What Does it Mean for Your Business?

    Key Points: In today’s Recommendations for Industry, we discuss the continuing evolution of COVID variants and what this means for your business. Read more below. The CDC has put out more information on long-COVID and Post-COVID conditions. The CDC currently discusses Post-COVID conditions by: “Some people who have been infected with the virus that causes […]

  • COVID Vaccine: How Effective Are They Against Variants?

    Key Points: In today’s Recommendations for Industry, we discuss how well the various COVID vaccines work against the variants. Read more below. The CDC estimates that, until now, about “60% of adults and 75% of children” have antibodies indicating that they’ve been infected with COVID-19 (CNN). Moderna has asked the FDA to authorize its vaccine […]

  • Number of Factors Keeping U.S. COVID Rates Low

    Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and the “gentle swell” of COVID in the U.S. Read more below. CDC: 58% of Americans have had COVID-19. New COVID-19 seroprevalence data from CDC show that the Omicron surge infected a huge swath of Americans, with overall seroprevalence rising from 33.5% in December of […]

  • Travel Mask Mandate “Outlawed” – What this Means to your Business

    Key Points: In today’s Recommendations for Industry, we discuss the dropping of the travel mask mandate. Read more below. Declaring the COVID-19 travel mask mandate to be unlawful, U.S. District Judge Kathryn Kimball Mizelle in Tampa said the mandate exceeded the authority granted to the CDC under federal public health law; that Congress had never […]